be utilized to uncover electronic indicators for a broad variety of mental illnesses, including autism, attention deficit hyperactivity disorder, psychosis, and Alzheimer’s, among many others.

According to the report published by Allied Market Research, the global Neurodiagnostics Market was estimated at $6.53 billion in 2020 and is expected to hit $12.89 billion by 2030, registering a CAGR of 7.0% from 2021 to 2030.